Margarida Barroso (0000-0002-0407-3181)

Personal information

Biography

Margarida Barroso is a Professor at the Department of Molecular and Cellular Physiology, Albany Medical College in Albany, New York. She received her Ph.D. in Genetics from the University of Lisbon/Gulbenkian Institute of Sciences in Portugal and was a post-doctoral fellow at the Department of Molecular Biology, Princeton University. She is a faculty instructor in several international imaging courses and has two issued patents on FRET imaging technology. Dr. Barroso is currently the Past-Past-President of the Histochemical Society.

Activities

Collapse all

Albany Medical Center Hospital: Albany, New York, US

2022-06-01 to present | Director of the Imaging Core Facility (Molecular and Cellular Physiology)

Employment

Margarida Barroso

https://orcid.org/0000-0002-0407-3181

Personal information

Emails & domains

Verified email domains

Websites & social links

Keywords

Countries

Biography

Activities

Employment (4)

Albany Medical Center Hospital: Albany, New York, US

Rensselaer Polytechnic Institute: Troy, NY, US

Albany Medical College: Albany, NY, US

Albany Medical College: Albany, NY, US

Education and qualifications (3)

Princeton University: Princeton, NJ, US

University of Lisbon: Lisbon, PT

University of Lisbon: Lisbon, PT

Professional activities (3)

SPIE: Bellingham, WA, US

Histochemical Society: Bethesda, MD, US

American Society for Cell Biology: Bethesda, MD, US

Funding (10)

AI enhanced lifetime-based mesoscopic in vivo imaging of tissue molecular heterogeneity

Artificial intelligence enhanced cancer cell classification based organelle morphology and topology

In vivo Macroscopic Fluorescence Lifetime Molecular Optical Imaging

Endosome-mitochondria interactions in breast cancer cells

Photon-counting X-ray and Optical Tomography for Preclinical Cancer Research

Role of tumor heterogeneity on receptor engagement

ROLE OF TUMOR HETEROGENEITY ON RECEPTOR ENGAGEMENT

Time-Resolved Wide-Field Molecular Optical Tomography

The 3D whole Body Distribution of NIR transferrin using FRET tomography imaging

REGULATION OF CYTOSKELETON AND MEMBRANE TRAFFIC BY P22

Works (50 of 114)

in vivo quantitative FRET small animal imaging: intensity versus lifetime-based FRET

Probing organoid metabolism using fluorescence lifetime imaging microscopy (FLIM): The next frontier of drug discovery and disease understanding.

Spatial topology of organelle is a new breast cancer cell classifier.

<i>INKILN</i> is a Novel Long Noncoding RNA Promoting Vascular Smooth Muscle Inflammation via Scaffolding MKL1 and USP10.

In vivo quantitative FRET small animal imaging: Intensity versus lifetime-based FRET.

Nuclear cytoglobin associates with HMGB2 and regulates DNA damage and genome-wide transcriptional output in the vasculature

Data for "In vitro and in vivo NIR Fluorescence Lifetime Imaging with a time-gated SPAD camera"

Quantitative label-free imaging of iron-bound transferrin in breast cancer cells and tumors

Complex Rab4-Mediated Regulation of Endosomal Size and EGFR Activation

Phosphorylation of GMFγ by c-Abl coordinates lamellipodial and focal adhesion dynamics to regulate airway smooth muscle cell migration.pdf

Fast fit-free analysis of fluorescence lifetime imaging via deep learning.

Phosphorylation of GMFγ by c-Abl Coordinates Lamellipodial and Focal Adhesion Dynamics to Regulate Airway Smooth Muscle Cell Migration.

Cardiomyocyte orientation modulated by the Numb family proteins-N-cadherin axis is essential for ventricular wall morphogenesis.

Resolvin D1 promotes the targeting and clearance of necroptotic cells.

Laser-based 3D bioprinting for spatial and size control of tumor spheroids and embryoid bodies.

Supporting Data for Fig. 2 &amp; S1 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 2 &amp; S1 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 3 &amp; S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 3 &amp; S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 3 &amp; S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 4 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 4 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 4 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 5 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 5 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 5 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 &amp; S3 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 6, 7 &amp; S3 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 &amp; S3-S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 &amp; S3-S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 &amp; S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Movie 1

Supporting Movie 1 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Movie 1 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Movie 1 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Movie 2 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Movie 2 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Movie 2 for "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short-lifetime near-infrared dyes and time-gated imaging.

Quantitative imaging of receptor-ligand engagement in intact live animals.

Comparison of illumination geometry for lifetime-based measurements in whole-body preclinical imaging.

AlliGator: A Phasor Computational Platform for Fast in vivo Lifetime Analysis

Raman Spectroscopic Analysis of Iron Transport across Membranes in Cells

TOWARD BAYESIAN INFERENCE OF THE SPATIAL DISTRIBUTION OF PROTEINS FROM THREE-CUBE FÖRSTER RESONANCE ENERGY TRANSFER DATA.

Golgi-Associated Protein Kinase C-ε Is Delivered to Phagocytic Cups: Role of Phosphatidylinositol 4-Phosphate.

Supporting Data for Fig. 2 & S1 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 2 & S1 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 3 & S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 3 & S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 3 & S2 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 & S3 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes"

Supporting Data for Fig. 6, 7 & S3 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 & S3-S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 & S3-S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"

Supporting Data for Fig. 6, 7 & S6 of "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using short lifetime near-infrared dyes and time-gated imaging"